Clients
TORONTO, May 13, 2021 /CNW/ www.treescorp.ca – Trees Corporation (“TREES” or the “Company“) is pleased to announce the closing of the acquisition of 5 retail cannabis stores in Ontario previously licensed under the name Metro Cannabis (the “Transaction“). Three of the acquired stores are open and will operate under the TREES Cannabis brand with the remaining 2 stores anticipated to open […]
CALGARY, AB, May 13, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSX-V:DB) (OTCQB:DBCCF), a premium cannabis producer, is pleased to provide a corporate update regarding record performance of its cannabis derivative products, operational developments at its Thunderchild facility and other key initiatives. Link to Decibel’s Investor Presentation “We are expanding our market share in […]
Newly Public RYAH Medtech Sets Table for Expansion
RYAH Group, Inc. (CSE: RYAH) and its wholly owned subsidiary RYAH Medtech Inc. began trading publicly May 10, 2021 on the Canadian Securities Exchange. The reverse takeover was nearly two years in the making, bringing RYAH’s suite of smart cannabis and plant-based medicine devices (and the accompanying treasure trove of data) to the public […]
True Leaf Launches Equity Crowdfunding for B.C. Craft Cannabis
Hub for craft growers will provide a new path to market for in-demand, quality cannabis Vernon, British Columbia–(Newsfile Corp. – May 10, 2021) – True Leaf Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FSE: TLAA) (“True Leaf” or the “Company”) today announced a unique opportunity for the public to invest in what it believes is […]
Newly Public Gage Cannabis on a Steep Growth Trajectory
Investors looking for value in the legal cannabis industry might be looking for some key indicators to point the way to companies of interest. Organizations operating in key and lucrative markets, showing fast revenue growth that looks like it will continue, and having experienced executives to guide the company through the various pitfalls of […]
Why Are Analysts So Bullish on Cybin?
The global psychedelics market is projected to grow from $4.75 billion to $10.75 billion by 2027, according to Research and Markets, representing a strong 12.36% compound annual growth rate. With more than 40 public companies in the psychedelics sector and an exchange-traded fund, there is no shortage of opportunities for investors interested in the space. […]
VANCOUVER, British Columbia, MAY 4, 2021 Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to announce that it has received its first purchase order for a commercial quantity of distillate oil valued at CAD $129,000 from a Canadian licensed producer whose products are distributed […]
Fiore Posts Strong Q1 Performance as Restructuring Pays Off
The cannabis industry reached US$22.9 billion in 2020, according to ReportLinker, which projects that it will grow at an 18.1% compound annual growth rate through 2026. In the U.S., the Biden administration promised to pursue cannabis decriminalization as a number of new states have moved to legalize medical and/or recreational cannabis. Fiore Cannabis Inc. […]
Invest in Cannabis Co-Manufacturing with The Galley
The U.S. cannabis industry is projected to double in size to $41.5 billion by 2025, according to New Frontier Data, driven by strong consumer demand, greater spending per consumer and the legalization of cannabis in new states. While cannabis flower remains popular, concentrates, edibles and other manufactured products have opened the door to a wider […]
The psychedelics industry is following in the same projectile footsteps of the cannabis industry and could be on its way to becoming a multi-billion dollar industry. With the potential to transform mental health treatments. Researchers from Johns Hopkins and other leading institutions have embraced advancements in psychedelic research which has spawned a growing list of […]
Medical Cannabis Tech and Data Company Going Public Soon
If cannabis is to be accepted by the medical community (meaning patients, doctors, researchers, pharma companies, regulators…), there is much to be done in terms of testing the plant, standardizing dosages, and cataloging its effects. After decades of prohibition, scientists are racing to determine and document the potential benefits of cannabis in the treatment of […]
Decibel’s Record Financial Results Reflect Strength of Craft Cannabis Market
A few years ago, as companies prepared for legalization of adult-use cannabis in Canada, there was a lot of talk about the eventual commodification of flower due to overproduction. The thinking was that price would be the driving factor in determining market success, but it hasn’t really played out that way to this point. […]
Microdosing: The Next Revolution in Psychedelics
The psychedelics industry has experienced a renaissance over the past few years as researchers have opened a pandora’s box of potential. From major depression to generalized anxiety to post-traumatic stress disorder, emerging research suggests that psychedelic substances could have a significant beneficial impact on hard-to-treat mental health disorders. As states liberalize their psychedelics regulations, microdosing […]
Opportunity Abounds in Cannabinoid Topicals Market
Cannabis topicals, including both CBD and THC containing products, are one of the fastest growing segments of the industry. According to Million Insights, the CBD skincare market is projected to grow at a 32.9% CAGR between 2019 and 2025 to reach $1.7 billion. The steep growth in the sector has led to some level of […]
Fiore Cannabis Sells B.C. Asset to Strengthen Focus on Core U.S. Markets
Company putting renewed focus on Nevada and California with Canadian asset sold and letters of intent cancelled Kelowna, British Columbia–(Newsfile Corp. – April 20, 2021) – Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today announced that it has terminated the Letter of Intent […]
Cookies and Gage Growth Corp.: A Recipe for Success in Michigan
National branding is very difficult to achieve in the cannabis industry. The federal ban on interstate cannabis commerce is the major obstacle, as most companies are unwilling or unable to set up full operations in multiple states. If a company were to choose the multi-state operator approach in the current environment, the varying regulations […]
KI findet die Nadel im Heuhaufen
Jedes Jahr werden Tausende von Molekülen als Medikamentenkandidaten für eine Vielzahl von Krankheiten hergestellt, synthetisiert und getestet. MagicMed Industries bringt diesen pharmazeutischen Entwicklungsansatz auf dem Gebiet der Psychedelika zum Einsatz, um neue therapeutische Alternativen für Patienten mit Problemen der Gehirn- und psychischen Gesundheit zu schaffen. Die Entdeckung der richtigen Moleküle ist jedoch ein gewaltiges […]
Every year, thousands of molecules are being created, synthesized and tested as drug candidates for a vast number of ailments. MagicMed Industries brings this pharmaceutical development approach to the field of psychedelics to create new therapeutic alternatives for patients with brain and mental health indications. However, discovering the right molecules is a massive undertaking. It […]
Psychedelics Then & Now: From Ancient Times to the Psychedelic Renaissance
Psychedelics have become one of the most promising classes of drugs in a generation, as well as an exciting new industry for investors. Despite their resurgence among researchers and investors, psychedelics have been used for thousands of years before they were criminalized in the 1970s in the United States and around the world. Let’s take […]
Fiore Cannabis: A Small Customer-focused Team Executes an Impressive Turnaround
The cannabis industry followed a familiar and predictable path over the past few years. In the early years, companies raised significant amounts of capital to build massive indoor cultivation operations in an attempt to scale at all costs. A handful of companies succeeded but most shut down due to a lack of capital, poor product […]
Psychedelics Wellness Company Delic: Proven Management Team with a Star-Studded Board
The psychedelics sector is quickly evolving into a multi-billion-dollar industry with a growing number of publicly traded companies. As with any new industry, there are many companies backed by little more than financiers looking to make a quick dollar before moving on to the next opportunity, which makes it important for investors to know who’s […]
The Rise of Specialization in Cannabis (and How to Invest)
Many early cannabis companies were forced into vertical-integration due to regulatory constraints. While it may make sense for cultivators to create extracts, it doesn’t always make sense for them to own commercial kitchens for confections or bottling machines for beverages, given the high capital costs and low return on investment. Most cultivators can earn a […]
Going Public Soon: Next Major Step for Gage Growth Corp.
The public markets have sometimes been good for cannabis companies, sometimes not so much. A look at trailing twelve month performance of two leading industry ETFs, an easy way to examine industry performance, indicates that now is one of the more favorable times. The AdvisorShares Pure US Cannabis ETF (NYSE Arca: MSOS) has climbed 7,000% […]
Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer
Oakville, Ontario–(Newsfile Corp. – March 30, 2021) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) (“Cardiol“ or the “Company“), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, today announced that Dr. Andrew Hamer has joined the Company as Chief Medical Officer (CMO), effective immediately. Dr. Hamer will lead the research and development […]
Ovation Science Takes Topical Cannabis to the Next Level with Its Patented Drug Delivery Technology
Cannabinoids have become some of the most popular health and wellness products in the world. For example, CBD-infused topicals are expected to reach $4.5 billion in sales by 2025, according to Cultivating Wellness, which represents a 540% increase since 2020. At the same time, topicals infused with THC or combinations of CBD and THC are […]
(OTCQB:KAYS) U.S. Cannabis Company to Leverage First-Mover Advantage in Greece and Israel- Initiating Coverage FT. LAUDERDALE, FL / ACCESSWIRE / March 22, 2021 / Kaya Holdings, Inc., (“KAYS” or the “Company”) (OTCQB:KAYS), confirmed today that Fundamental Research Corp (“FRC”) has initiated coverage of KAYS with a Buy Rating and Fair Value Estimate of $0.89. According to […]
TORONTO, March 19, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce positive results of a pre-clinical study evaluating the efficacy of psilocybin in the treatment […]
ManifestSeven Announces Distribution Partnership with Eel River Organics
M7’s business-to-business division, Highlanders Distribution, to serve as exclusive distributor of ERO’s diverse line of cannabis products throughout California IRVINE, Calif., March 18, 2021 /PRNewswire/ — ManifestSeven Holdings Corporation (CSE: MSVN) (OTCMKTS: MNFSF) (“M7” or the “Company“), California’s first integrated omnichannel platform for legal cannabis, today announced that its business-to-business division, Highlanders Distribution, has entered into a distribution partnership with Eel River […]
The Psybrary™: 12 Choose Your Own Adventure Stories, Millions of Endings
MagicMed’s PsybraryTM is a remarkable and impressive achievement that, pending patent approval, could provide patent protection to more than an estimated 125 million derivatives. While 125 million derivatives is a big number, two clarifications should be made. Firstly, this number does not indicate that they have locked a small army of scientists away to fulfill […]
Delic’s Vision Comes Into Focus With a Flurry of Acquisitions
Investors have many different options when it comes to building exposure into the psychedelics sector within their portfolios. While some companies are undergoing large-scale and years-long clinical trials to prove efficacy, others are opening wellness clinics or cultivating mushrooms in legal jurisdictions. Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) is a relatively new player […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
Flora is building a connected, design-led collective, of plant-based wellness and lifestyle brands, that delivers the most compelling customer experiences in the world, one community at a time.
Xphyto Therapeutics Corp. was created to bridge the gap between traditional cannabis-based medicine and modern scientific approaches to therapeutic validation.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
